Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Discovery

Discovery of the Rh Factor

Also Known As Rhesus Factor
Cardiovascular and Hematological Discovery

Karl Landsteiner and Alexander Wiener identified the Rh factor in 1939, working from serum produced by immunizing rabbits with red blood cells from a rhesus macaque, which gave the antigen its name. Philip Levine and Rufus Stetson published the first clinical case report the same year, describing the severe hemolytic transfusion reaction and hemolytic disease of the newborn that follow when an Rh-negative mother carries an Rh-positive fetus. Roughly 80 to 85 percent of people carry the Rh(D) antigen, making the Rh system the second most clinically significant blood group system after ABO; the discovery led directly to prenatal Rh screening and prophylaxis that dramatically improved maternal and fetal outcomes.

Facts
Discovery Year
1939 1
Discoverer
Karl Landsteiner and Alexander Wiener; the clinical significance was independently reported the same year by Philip Levine and Rufus Stetson. 1
Classification
Type/Classification
Disease Mechanism 1
Connections

Associated With

Source Wikipedia: Rh Blood Group System

Discovery of the Rh blood group factor directly explained the maternal-fetal blood incompatibility that causes hemolytic disease of the newborn.

Discovered By

Source Wikipedia: Rh Blood Group System
Sources
1. Wikipedia: Rh Blood Group System
Wikipedia
  • Discoverers; Naming origin; Significance
    The serum that led to the discovery was produced by immunizing rabbits with red blood cells from a rhesus macaque.
  • Year of discovery
  • entity description, Discovery of the Rh Factor
    Philip Levine and Rufus Stetson published the first clinical case report the same year, describing the severe hemolytic transfusion reaction and hemolytic disease of the newborn that follow when an Rh-negative mother carries an Rh-positive fetus.
  • Discovered By: Karl Landsteiner
  • Associated With: Blood Transfusion
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.